Slovak patients see co-payment increase for reimbursed products

80.7 million packets of fully or partially reimbursed drugs were dispensed from Slovak pharmacies in 2017, compared with 83.2 million packages dispensed in 2016, the country’s National Health Information Centre said.

Public health insurance providers paid for the reimbursed medicines €886.4m in 2017, down by 2.8% year on year, with patient co-payments growing by 3.3% to €145.8m.

Slovak patients also purchased 38.4 million packages of OTC drugs last year, paying for them €181.9m, up by 6.9% compared with 2016.

The most frequently purchased OTC medicines included products to treat respiratory diseases, while drugs used to treat cardiovascular conditions were among the most frequently prescribed drugs in Slovakia in 2017.

In addition, the total of 4.6 million packages of fully and partially reimbursed dietary foods were dispensed by Slovak pharmacies in 2017, down by 9.7% year on year. Public health insurers paid €26m for the dispensed products, up by 1.3% year on year, while patient co-payment level amounted to around €4m, up by 0.2% year on year.

The number of reimbursed medical devices and supplies dispensed to Slovak patients in 2017 amounted to 131.2 million pieces/packets, an increase by 2.1% compared with 2016. Expenses of public health insurers on prescribed medical supplies dropped by 5.3% to €193.5m, while patient co-payments went up by 17.6% to €8.7m.